The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country
AI-enabled learning platform to enhance clinical quality, patient outcomes, and staff engagement across Eastern India network
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
The innovation is particularly suited for bone and cartilage repair
Subscribe To Our Newsletter & Stay Updated
